| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 07/06/2011 | CN101180277B Method for production of 1-alkyl-3-phenyluracils |
| 07/05/2011 | US7973160 Nitrogen-containing aromatic derivatives |
| 07/05/2011 | US7973045 Anhydrous form of dasatinib and process for preparation thereof |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7973042 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 07/05/2011 | US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 07/05/2011 | US7973035 Inhibitors of C-FMS kinase |
| 07/05/2011 | US7973028 Pyrimidine compound and pests controlling composition containing the same |
| 07/05/2011 | CA2583907C Heteroaryl-substituted alkyne compounds and method of use |
| 07/05/2011 | CA2496194C Phenyl-substituted pyrazolopyrimidines |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2446136C Pyruvate derivatives |
| 06/30/2011 | WO2011079305A1 Therapeutic compounds |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2011077171A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity |
| 06/30/2011 | WO2011077043A2 Phenol derivatives and pharmaceutical or cosmetic use thereof |
| 06/30/2011 | WO2011076813A1 Preparation process of erlotinib |
| 06/30/2011 | WO2011076723A1 Amino-heteroaryl derivatives as hcn blockers |
| 06/30/2011 | US20110160455 Preparation of Aminopyrimidine Compounds |
| 06/30/2011 | US20110160451 2-Aminopyrimidine modulators of the histamine H4 receptor |
| 06/30/2011 | US20110160231 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof |
| 06/30/2011 | US20110160225 Compositions and methods of use for treating or preventing lipid related disorders |
| 06/30/2011 | US20110160221 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 06/30/2011 | US20110159019 2,4-diaminopyrimidine compound |
| 06/30/2011 | CA2784822A1 Phenol derivatives and pharmaceutical or cosmetic use thereof |
| 06/30/2011 | CA2783209A1 Amino-heteroaryl derivatives as hcn blockers |
| 06/29/2011 | EP2338882A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines |
| 06/29/2011 | EP1755606B2 Quinazolinone derivatives useful as vanilloid antagonists |
| 06/29/2011 | EP1476436B1 Method for producing 2-anilino-4,6-dimethylpyrimidine |
| 06/29/2011 | EP1326834B1 2-substituted heterocyclic compounds |
| 06/29/2011 | CN1812974B N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 06/29/2011 | CN102112450A 5-alkynyl-pyrimidines |
| 06/29/2011 | CN102108064A Method for preparing N4-benzoylcytosine |
| 06/28/2011 | US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/28/2011 | US7968703 Process and methods for the preparation of optically active cis-2-hydroxymethyl-4- (cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof |
| 06/28/2011 | US7968577 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| 06/28/2011 | US7968560 Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
| 06/28/2011 | US7968553 Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968545 Compositions useful as inhibitors of voltage-gated ion channels |
| 06/28/2011 | US7968537 Pyrimidine compound and pests controlling composition containing the same |
| 06/28/2011 | CA2649083C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2479039C 2,2-bis(hydroxymethyl)cyclopropylidenemethyl -purines and -pyrimidines as antiviral agents |
| 06/28/2011 | CA2322008C 2'-fluoronucleosides |
| 06/23/2011 | WO2011075699A2 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 06/23/2011 | WO2011074016A1 Novel polymorphic forms of rosuvastatin calcium and process for preparation of the same |
| 06/23/2011 | WO2011073959A2 Crystal structure of the hiv-1 reverse transcriptase bound to a nucleotide-competitive reverse transcriptase inhibitor and the use thereof |
| 06/23/2011 | WO2011073232A1 Process for the preparation of key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
| 06/23/2011 | WO2011073143A1 Substituted cyanobutyrates having herbicidal action |
| 06/23/2011 | WO2011072791A1 Sphingosine kinase inhibitors |
| 06/23/2011 | WO2011022393A3 Phosphatidylcholine transfer protein inhibitors |
| 06/23/2011 | WO2010076009A8 Pyrimidine derivatives and the use thereof for combating undesired plant growth |
| 06/23/2011 | US20110152522 Method for the production of 3-phenyl(thio) uracils and dithiouracils |
| 06/23/2011 | US20110152521 Method for Producing Quinazoline Derivative |
| 06/23/2011 | US20110152518 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 06/23/2011 | US20110152303 Chemical Compounds |
| 06/23/2011 | US20110152301 Compounds that Inhibit HIV Particle Formation |
| 06/23/2011 | US20110152300 2-aldoximino-5-fluoropyrimidine derivatives |
| 06/23/2011 | US20110152292 Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | CA2784830A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 06/23/2011 | CA2784075A1 Inhibitors of sphingosine kinase |
| 06/22/2011 | EP2336116A1 Process for the preparation of key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
| 06/22/2011 | EP2336115A1 Dihydropyrimidine compounds and use thereof for the treatment of viral diseases |
| 06/22/2011 | EP2336110A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines |
| 06/22/2011 | EP2336104A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide |
| 06/22/2011 | EP2335701A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2011 | EP2334645A1 Process for the synthesis of halogenated cyclic compounds |
| 06/22/2011 | EP2334643A1 Phenethylamide derivatives and their heterocyclic analogues |
| 06/22/2011 | EP2334380A1 Anti-ligands molecules and biological applications |
| 06/22/2011 | EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
| 06/22/2011 | EP2260026B1 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 06/22/2011 | EP2091924B1 Pyrimidine derivatives and their use as pesticides |
| 06/22/2011 | CN1763015B Preparation method and intermediate of rosuvastatin and its pharmaceutical salts |
| 06/22/2011 | CN1701073B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/22/2011 | CN1659149B Method for producing 4,6-dichloro-5-fluoropyrimidine |
| 06/22/2011 | CN102105530A Composition comprising phosphorescence emitting compound, and light emitting element using the composition |
| 06/22/2011 | CN102105464A Wnt protein signalling inhibitors |
| 06/22/2011 | CN101463013B Preparation of erlotinid hydrochloride |
| 06/22/2011 | CN101148439B Preparing method for gefitinib |
| 06/22/2011 | CN101031569B Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
| 06/21/2011 | US7964608 Tricyclic compounds as modulators of TNF-α synthesis |
| 06/21/2011 | US7964592 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/21/2011 | US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth |
| 06/21/2011 | US7964204 Isoxazolines for controlling invertebrate pests |
| 06/21/2011 | CA2554437C Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2442114C N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/16/2011 | WO2011071821A1 Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof. |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144321 Synthetic intermediates and processes |
| 06/16/2011 | US20110144092 Substituted alkyl pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144066 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 06/16/2011 | US20110143387 Highly water-soluble, cationic luminescent labels |
| 06/16/2011 | CA2781431A1 Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof |
| 06/15/2011 | EP2332962A1 Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions |
| 06/15/2011 | EP2332953A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient |